Sharing successes, challenges and daily happenings in the Department of Medicine
ARTICLE: Diabetes, Subclinical Myocardial Injury or Stress, and Risk of Heart Failure Subtypes: The Jackson Heart Study AUTHORS: Arnaud D Kaze, Alain G Bertoni, Ervin R Fox, Michael… Read More »Diabetes, Subclinical Myocardial Injury or Stress, and Risk of Heart Failure Subtypes: The Jackson Heart Study
ARTICLE: Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome AUTHORS: Nikhil Ranjan, Michael A Cole, Gloria F Gerber, Mark A Crowther, Evan M Braunstein, Daniel Flores-Guerrero, Kathy… Read More »Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome
ARTICLE: Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study AUTHORS: Joowhan Sung, Mariam Nantale, Annet Nalutaaya, Patrick Biché, James… Read More »Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study
ARTICLE: Dynamic Risk Prediction of Graft Failure After Deceased Donor Kidney Transplant AUTHORS: Heather Thiessen Philbrook, David G Hu, Sumit Mohan, Peter P Reese, Mona Doshi, Divyanshu Malhotra, Sherry G Mansour, Isaac… Read More »Dynamic Risk Prediction of Graft Failure After Deceased Donor Kidney Transplant
ARTICLE: Post-COVID-19 cardiovascular disease risk in kidney transplant recipients AUTHORS: Mary G Bowring, Kasama Manothummetha, Veraprapas Kittipibul, Lucy X Li, Robin K Avery, Willa Cochran, Sean Ellis, Ilan S Wittstein, Dorry L Segev, Christine… Read More »Post-COVID-19 cardiovascular disease risk in kidney transplant recipients
ARTICLE: Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseases AUTHORS: Taylor L Carlson, Kevin Colbert, Marcela Vieira, Florence V Guerina, Christine L… Read More »Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseases
ARTICLE: Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia AUTHORS: Fengting Wu, Milica Moskovljevic, Filippo Dragoni, Sahana Jayaraman, Nathan L… Read More »Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia
ARTICLE: Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE AUTHORS: Eduardo Gómez-Bañuelos, Alessandra Ida Celia, Maria Isabel Trejo-Zambrano, Jesus Aureliano Robles-De Anda, Merlin Paz, Shruti Chaturvedi, Fabrizio… Read More »Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE
ARTICLE: Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2… Read More »Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial
ARTICLE: Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis AUTHORS: Andrea Fava, Jill Buyon, Laurence Magder, Jeff Hodgin, Avi… Read More »Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis